Company Quick10K Filing
Bruker
10-Q 2020-03-31 Filed 2020-05-11
10-K 2019-12-31 Filed 2020-03-27
10-Q 2019-09-30 Filed 2019-11-04
10-Q 2019-06-30 Filed 2019-08-09
10-Q 2019-03-31 Filed 2019-05-08
10-K 2018-12-31 Filed 2019-03-01
10-Q 2018-09-30 Filed 2018-11-09
10-Q 2018-06-30 Filed 2018-08-09
10-Q 2018-03-31 Filed 2018-05-10
10-K 2017-12-31 Filed 2018-03-16
10-Q 2017-09-30 Filed 2017-11-09
10-Q 2017-06-30 Filed 2017-08-09
10-Q 2017-03-31 Filed 2017-05-10
10-K 2016-12-31 Filed 2017-03-01
10-Q 2016-09-30 Filed 2016-11-09
10-Q 2016-06-30 Filed 2016-08-05
10-Q 2016-03-31 Filed 2016-05-06
10-K 2015-12-31 Filed 2016-02-29
10-Q 2015-09-30 Filed 2015-11-06
10-Q 2015-06-30 Filed 2015-08-07
10-Q 2015-03-31 Filed 2015-05-08
10-K 2014-12-31 Filed 2015-02-27
10-Q 2014-09-30 Filed 2014-11-07
10-Q 2014-06-30 Filed 2014-08-08
10-Q 2014-03-31 Filed 2014-05-09
10-K 2013-12-31 Filed 2014-02-27
10-Q 2013-09-30 Filed 2013-11-08
10-Q 2013-06-30 Filed 2013-08-08
10-Q 2013-03-31 Filed 2013-05-09
10-K 2012-12-31 Filed 2013-02-28
10-Q 2012-09-30 Filed 2012-11-08
10-Q 2012-06-30 Filed 2012-08-09
10-Q 2012-03-31 Filed 2012-05-09
10-K 2011-12-31 Filed 2012-02-29
10-Q 2011-09-30 Filed 2011-11-09
10-Q 2011-06-30 Filed 2011-08-09
10-Q 2011-03-31 Filed 2011-05-09
10-K 2010-12-31 Filed 2011-03-01
10-Q 2010-09-30 Filed 2010-11-08
10-Q 2010-06-30 Filed 2010-08-09
10-Q 2010-03-31 Filed 2010-05-10
10-K 2009-12-31 Filed 2010-03-12
8-K 2020-05-21
8-K 2020-05-06
8-K 2020-03-27
8-K 2020-03-03
8-K 2020-02-18
8-K 2020-01-13
8-K 2019-12-11
8-K 2019-10-31
8-K 2019-08-01
8-K 2019-05-29
8-K 2019-05-20
8-K 2019-05-09
8-K 2019-05-02
8-K 2019-04-25
8-K 2019-02-14
8-K 2019-02-07
8-K 2018-11-04
8-K 2018-11-01
8-K 2018-08-02
8-K 2018-06-06
8-K 2018-05-21
8-K 2018-05-03
8-K 2018-03-12
8-K 2018-02-28
8-K 2018-02-16
8-K 2018-02-08

Bruker Financials

BRKR Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Illumina (ILMN) 44,722 69% 35.1 14% 7,089 2,650 3,458 2,395 973 1,255 44,038
Agilent Technologies (A) 24,292 54% 18.0 9% 9,452 4,704 5,163 2,805 877 1,368 24,690
Mettler Toledo (MTD) 17,554 58% 26.5 21% 2,636 2,198 2,983 1,720 550 700 18,558
Waters (WAT) 15,473 18% 31.8 15% 2,561 2,446 2,405 428 392 513 16,324
Bio-Rad Laboratories (BIO) 10,341 55% 12.0 5% 7,177 2,046 2,304 1,259 377 850 10,215
PerkinElmer (PKI) 9,500 48% 25.3 4% 6,489 3,782 2,835 1,374 234 449 11,362
Bruker (BRKR) 6,836 48% 23.2 9% 2,352 1,507 2,026 972 207 305 7,055
Coherent (COHR) 3,296 34% 37.6 3% 2,083 798 1,431 486 54 79 2,977
Accelerate Diagnostics (AXDX) 1,034 45% -15.4 -58% 147 137 8 3 -85 -72 1,112
Pacific Biosciences of California (PACB) 862 33% -7.4 -79% 146 95 82 27 -115 -113 840
Fluidigm (FLDM) 852 40% -16.2 -19% 269 107 117 46 -52 -51 824
Quanterix (QTRX) 607 39% -12.8 -22% 176 39 52 20 -39 -39 501
EyePoint Pharmaceuticals (EYPT) 194 67% -2.9 -101% 79 63 12 8 -80 -72 209
Harvard Bioscience (HBIO) 130 55% 33.8 -1% 163 86 119 66 -2 5 175
HTG Molecular Diagnostics (HTGM) 36 48% 0.2 -29% 51 23 14 7 -15 -13 -2
Precipio (PRPO) 20 4% -2.2 -42% 23 7 6 0 -9 -9 19
Astrotech (ASTC) 11 17% -1.4 -144% 5 4 0 0 -7 -7 10
Bionano Genomics (BNGO) 7 29% 0.1 -81% 19 27 11 3 -16 -13 -1
Aethlon Medical (AEMD) 0 0% 0.1 -579% 1 1 0 0 -7 -7 -0

Balance Sheet ($MM)2011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash193170196246230240242311269251307439454390329320334321331267210232279342281221268329288262275326303286300
Accounts Receivable250274271283262249265289273300298308295280269293228240242235233207224244225240270319314279323357360348359
Inventory572619601576648620633612622602632590620612567477474486478422460471483440476505515486518509519510542595587
PP&E247266249572262259272665280288297699297293265623229233232604239237239616241253260688270259261692268282278
Assets1,6241,7001,6701,7101,7971,7501,8001,8561,8121,8021,9361,9882,0282,0041,9111,8651,7731,8201,8431,7311,7401,7201,7981,8081,8401,9131,9621,9481,8301,8061,8892,1292,2422,3502,352
Accounts Payable8182767287777870767083751161029876878487729588938695929591105105100104126124117
Long-Term Debt7910294303320321337337337336356355355356355355355365371267302343365412385431480416221221241341335494519
Liabilities1,0561,0721,0711,0891,1391,1111,1071,1501,1231,0831,1591,1421,1651,1241,1031,0991,0571,0601,0831,0051,0381,0571,1041,1221,1151,1571,2301,2231,0491,0291,0721,2321,3291,4891,507
Stockholders' Equity568627600622659639693707689719777846863880808766716761760726702663694686725756732725782777817897913861845
Income Statement ($MM)2011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue357401418475406421448517393455439552424457420508354396396478375372394470385415436530432444467554461490521
Cost of Revenue1922182292572152322372752192532463162442572522921932272292672092022093920823223846232238244281247260267
Gross Profit165184189218190188211242174202193236180200167216160169168212167170185220176183198255199207223273215230254
R&D45444445485245504946464946454242373834373637383838414144434642464846
SG&A8998101119104111103124107107106118110115108118959896103931019710098104103112110118106120124125
Tax9101913129182131210186163175211553-419102010928122181122
Net Income122320401510401362317351017626723136124154769222438-327324478313762
Cash Flow ($MM)2011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-29492537091-18-7381311813146927-254150-141836913335104443628141152
Cash Investing-10-22-29-32-18-15-28-14-18-20-8-8-75-53-66-6-16-37-44-7719-40-714744108-46-29-27-80-13
Cash Financing-4-10-71531610222221304-5-0-167-42-1-1126-32-39-90-199-515-950-20